{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:31Z","timestamp":1792979911377,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SERPINC1 is a glycoprotein that regulates blood coagulation. SERPINC1 congenital or acquired deficiencies represent a significant risk factor for thromboembolic disease. SERPINC1 acquired defects are observed in very few cases and can occur in many clinical conditions such as treatment with <jats:sc>l<\/jats:sc>-asparaginase or oral contraceptive (particularly estrogen derivatives), but these conditions are not routinely investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 50-year-old Caucasian woman who took gestodene 75\u00a0\u00b5g\/ethinylestradiol 20\u00a0\u00b5g as oral contraceptive, was sent to our thrombophilia clinic because, on thrombophilia testing, a reduction of SERPINC1 (74%) and a slight increase in circulating D-dimer and homocysteine were found. We investigated triggers of such SERPINC1 reduction, and identified gestodene 75\u00a0\u00b5g\/ethinylestradiol 20\u00a0\u00b5g use as the most likely candidate. Two months after the discontinuation of the oral contraceptive, SERPINC1 value returned to normal (92%) and D-dimer and homocysteine were normalized.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Each patient has a different sensitivity to contraceptive use. Genetic (or epigenetic) regulation of anticoagulant proteins might account for a different rate of consumption of anticoagulant proteins as oral contraceptives and probably determine the susceptibility to thrombotic events.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04038-1","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T23:02:09Z","timestamp":1690498929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acquired SERPINC1\/antithrombin deficiency during oral contraceptive consumption: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"D.","family":"Denora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pellicori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. G.","family":"Sisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Span\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Biolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"10","key":"4038_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","volume":"67","author":"PS Maclean","year":"2007","unstructured":"Maclean PS, Tait RC. Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options. Drugs. 2007;67(10):1429\u201340. https:\/\/doi.org\/10.2165\/00003495-200767100-00005.","journal-title":"Drugs"},{"issue":"3","key":"4038_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/1054-139X(94)00188-K","volume":"17","author":"MJ Werner","year":"1995","unstructured":"Werner MJ. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use. J Adolesc Health. 1995;17(3):189\u201392. https:\/\/doi.org\/10.1016\/1054-139X(94)00188-K.","journal-title":"J Adolesc Health"},{"issue":"6","key":"4038_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","volume":"14","author":"MM Patnaik","year":"2008","unstructured":"Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008;14(6):1229\u201339. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01830.x.","journal-title":"Haemophilia"},{"issue":"2","key":"4038_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.12865\/CHSJ.40.02.12","volume":"40","author":"AM G\u0103man","year":"2014","unstructured":"G\u0103man AM, G\u0103man GD. Deficiency of antithrombin III (AT III)\u2014case report and review of the literature. Curr Health Sci J. 2014;40(2):141\u20133. https:\/\/doi.org\/10.12865\/CHSJ.40.02.12.","journal-title":"Curr Health Sci J"},{"issue":"5893","key":"4038_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/bmj.4.5893.631","volume":"4","author":"B Astedt","year":"1973","unstructured":"Astedt B, Isacson S, Nilsson IM, Pandolfi M. Thrombosis and oral contraceptives: possible predisposition. Br Med J. 1973;4(5893):631\u20134. https:\/\/doi.org\/10.1136\/bmj.4.5893.631.","journal-title":"Br Med J"},{"issue":"1","key":"4038_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/00016348409156274","volume":"63","author":"GH Weenink","year":"1984","unstructured":"Weenink GH, Kahl\u00e9 LH, Lamping RJ, ten Cate JW, Treffers PE. Antithrombin III in oral contraceptive users and during normotensive pregnancy. Acta Obstet Gynecol Scand. 1984;63(1):57\u201361. https:\/\/doi.org\/10.3109\/00016348409156274.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6 Suppl","key":"4038_CR7","doi-asserted-by":"publisher","first-page":"844S","DOI":"10.1378\/chest.08-0761","volume":"133","author":"SM Bates","year":"2008","unstructured":"Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):844S-886S. https:\/\/doi.org\/10.1378\/chest.08-0761.","journal-title":"Chest"},{"issue":"2","key":"4038_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-2008-1040654","volume":"4","author":"ET Mays","year":"1984","unstructured":"Mays ET, Christopherson W. Hepatic tumors induced by sex steroids. Semin Liver Dis. 1984;4(2):147\u201357. https:\/\/doi.org\/10.1055\/s-2008-1040654.","journal-title":"Semin Liver Dis"},{"issue":"7","key":"4038_CR9","first-page":"634","volume":"13","author":"OM Taube","year":"1992","unstructured":"Taube OM, Rouse MR, D\u2019Angelo L. Oral contraceptives and venous thromboses in adolescents undergoing elective surgery: a case report, and review of the literature. J Adolesc Health. 1992;13(7):634\u20136.","journal-title":"J Adolesc Health"},{"issue":"4","key":"4038_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00716359","volume":"13","author":"R Fawer","year":"1978","unstructured":"Fawer R, Dettling A, Weihs D, Welti H, Schelling JL. Effect of the menstrual cycle, oral contraception and pregnancy on forearm blood flow, venous distensibility and clotting factors. Eur J Clin Pharmacol. 1978;13(4):251\u20137. https:\/\/doi.org\/10.1007\/BF00716359.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/107602969900500112","volume":"5","author":"RN Prasad","year":"1999","unstructured":"Prasad RN, Koh SC, Viegas OA, Ratnam SS. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel. Clin Appl Thromb Hemost. 1999;5(1):60\u201370. https:\/\/doi.org\/10.1177\/107602969900500112.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"4038_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijgo.12455","volume":"141","author":"MV Dragoman","year":"2018","unstructured":"Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141(3):287\u201394. https:\/\/doi.org\/10.1002\/ijgo.12455.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4038_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/13625189709049932","volume":"2","author":"G Creatsas","year":"1997","unstructured":"Creatsas G, Kontopoulou-Griva I, Deligeoroglou E, Digenopoulou L, Tsangaris A, Kallipolitis G, Milingos S, Michalas S. Effects of two combined monophasic and triphasic ethinylestradiol\/gestodene oral contraceptives on natural inhibitors and other hemostatic variables. Eur J Contracept Reprod Health Care. 1997;2(1):31\u20138. https:\/\/doi.org\/10.1080\/13625189709049932.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"4038_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0010-7824(95)00271-5","volume":"53","author":"UH Winkler","year":"1996","unstructured":"Winkler UH, Schindler AE, Endrikat J, D\u00fcsterberg B. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol. Contraception. 1996;53(2):75\u201384. https:\/\/doi.org\/10.1016\/0010-7824(95)00271-5.","journal-title":"Contraception"},{"issue":"3","key":"4038_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","volume":"103","author":"LA Norris","year":"1996","unstructured":"Norris LA, Bonnar J. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Br J Obstet Gynaecol. 1996;103(3):261\u20137. https:\/\/doi.org\/10.1111\/j.1471-0528.1996.tb09716.x.","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"4038_CR16","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood.V79.6.1428.1428","volume":"79","author":"MA Blajchman","year":"1992","unstructured":"Blajchman MA, Fernandez-Rachubinski F, Sheffield WP, Austin RC, Schulman S. Antithrombin-III-Stockholm: a codon 392 (Gly\u2013\u2013Asp) mutation with normal heparin binding and impaired serine protease reactivity. Blood. 1992;79(6):1428\u201334.","journal-title":"Blood"},{"issue":"2","key":"4038_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00001721-199404000-00023","volume":"5","author":"A Girolami","year":"1994","unstructured":"Girolami A, Zanardi S, Simioni P, Tormene D. Prolonged oral contraceptive therapy in a woman with an antithrombin III abnormality involving heparin binding (type IIc) without thromboembolic complications. Blood Coagul Fibrinolysis. 1994;5(2):313\u20134. https:\/\/doi.org\/10.1097\/00001721-199404000-00023.","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04038-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T23:02:56Z","timestamp":1690498976000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04038-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04038-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}